Author Agreement

  1. Originality

The author confirms the manuscript is original, unpublished, and not under review elsewhere, with all prior work properly cited.

  1. Copyright Retention

The author retains full copyright; AFRIDINAR does not require authors to transfer copyright, only to grant permission for open licensing as described below.

  1. Open Licensing

Published work is licensed under CC BY 4.0, allowing free reuse, translation, and redistribution with attribution.

  1. Publication Costs

Publication in AFRIDINAR's first year is entirely free. From the second year, a modest income-tiered fee applies ($0–$100 depending on the author's country income classification), with an automatic no-questions-asked waiver available on request.

  1. Peer Review

Manuscripts are reviewed by at least two independent reviewers under double-blind conditions, with a target decision time of three to four weeks.

  1. Research Integrity

Submissions are screened for plagiarism prior to review. Authors reporting research involving human participants confirm informed consent was obtained. AFRIDINAR follows COPE principles in handling authorship, conflicts of interest, and post-publication concerns.

  1. Authorization on Behalf of Co-Authors

The corresponding author confirms that all listed co-authors have approved the final manuscript and agree to its submission under these terms.